Associated Papers
Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA.
Li J et al.
Oncotargets and Therapy, 2022
Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review.
Karlsen EA et al.
Cells, 2021
Mechanisms of resistance to EGFR tyrosine kinase inhibitors.
Huang L et al.
Acta Pharmaceutica Sinica. B, 2015
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.
Stewart EL et al.
Translational Lung Cancer Research, 2015
DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.
Yeh P et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2013
The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case Example.
Li-Wan-Po A et al.
The Annals of Pharmacotherapy, 2011
EGFR mutations and the terminal respiratory unit.
Yatabe Y
Cancer Metastasis Reviews, 2010
Select a paper to view details